AKRO is currently covered by 5 analysts with an average potential upside of $15.53 (51.06%) backed by displayed 3 price targets and 23 ratings.
Analysts average stock forecasts to be materialized ratio is 46% with an average time for these price targets to be met of 238 days.
Highest price target for AKRO is 53, Lowest price target is 12, average price target is 32.5. For detailed individual stock analysts price targets on AKRO go to the chart section.
Most recent stock forecast was given by ED ARCE from HCWAINWRIGHT on 07-Jun-2023. First documented stock forecast 01-Jul-2020.
Currently, out of the existing stock ratings of AKRO - 9 which are a Hold (42.86%), 12 which are a Buy (57.14%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
64
$11.51 (21.93%)
62
3 days ago
0/5 (0%)
$23.48 (68.53%)
Buy
59
$6.51 (12.40%)
58
24 days ago
2/4 (50%)
$21.29 (87.55%)
606
Buy
65
$12.51 (23.83%)
65
2 months 18 days ago
2/4 (50%)
$12.78 (35.28%)
315
Hold
40
$-12.49 (-23.80%)
30
7 months 3 days ago
4/5 (80%)
$10.06 (32.94%)
163
Hold
50
$-2.49 (-4.74%)
10
8 months 27 days ago
1/2 (50%)
$10.02 (31.01%)
106
What is AKRO(Akero Therapeutics, Inc) average time for price targets to be met?
Which analyst has the current highest performing score on AKRO(Akero Therapeutics, Inc) with a proven track record?
Which analyst has the current lower performing score on AKRO(Akero Therapeutics, Inc) with a proven track record?
